InsideArbitrage Event Driven Monitor – February 23, 2024

Merger Arbitrage

1. HARP: Harpoon Therapeutics (HARP) HSR waiting period for its planned sale to Merck (MRK) expired on February 21, 2024. The special stockholder meeting has been scheduled to be held virtually on March 8, 2024.
2. AMAM: Ambrx Biopharma (AMAM) HSR waiting period for its planned sale to Johnson & Johnson (JNJ) expired on February 21, 2024. Ambrx has scheduled the special meeting of stockholders for March 6, 2024, to vote on adoption of the Merger Agreement.
3. X: February 22, 2024: According to Bloomberg, President Joe Biden’s administration is examining Nippon Steel’s connections to China, a potential stumbling block for the Japanese giant’s politically contentious deal to acquire American rival United States Steel (X).

You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.

Only plus or premium subscribers can access this post. Subscribe today.